GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Buyback Yield %

Optigenex (Optigenex) Buyback Yield % : 0.00 (As of Jun. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Optigenex Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Optigenex's current buyback yield was 0.00%.


Optigenex Buyback Yield % Historical Data

The historical data trend for Optigenex's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex Buyback Yield % Chart

Optigenex Annual Data
Trend Dec04 Dec05 Dec06 Dec07
Buyback Yield %
- - - -

Optigenex Quarterly Data
Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Optigenex's Buyback Yield %

For the Diagnostics & Research subindustry, Optigenex's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optigenex's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Optigenex's Buyback Yield % falls into.



Optigenex Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Optigenex's Buyback Yield for the fiscal year that ended in Dec. 2007 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) /
=N/A%

Optigenex's annualized Buyback Yield for the quarter that ended in Jun. 2008 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 0.0462
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Jun. 2008) data.


Optigenex Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Optigenex's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Optigenex (Optigenex) Business Description

Traded in Other Exchanges
N/A
Address
901 Sam Rayburn Highway, Melissa, TX, USA, 75454
Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.
Executives
Richard S Serbin director, 10 percent owner, officer: CEO, President & Secretary 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines